What is the best next step in managing a 52-year-old man with hypertension, type 2 diabetes mellitus (T2DM), and heart failure with preserved ejection fraction (HFpEF) who is scheduled for total knee arthroplasty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Cardiac Risk Assessment for Total Knee Arthroplasty

Based on the available evidence, the best next step for this 52-year-old man with hypertension, T2DM, and HFpEF scheduled for total knee arthroplasty is to assess exercise capacity (Option D).

Rationale for Assessing Exercise Capacity

The patient has several cardiac risk factors and a Revised Cardiac Risk Index (RCRI) score indicating a 6% 30-day risk of cardiovascular events, which is considered elevated. In patients with heart failure, particularly HFpEF, exercise capacity assessment provides crucial information about:

  1. Functional cardiac reserve
  2. Ability to tolerate the hemodynamic stress of surgery
  3. Risk stratification beyond what the RCRI score alone provides

Clinical Considerations

  • Heart Failure Status: The patient has HFpEF, which affects approximately half of all heart failure patients and is associated with:

    • Severe exercise intolerance
    • Exertional dyspnea
    • Early-onset fatigue with physical activity 1
    • Impaired quality of life and increased mortality risk
  • Comorbidities: The combination of HFpEF with T2DM and hypertension creates a high-risk profile:

    • T2DM in HFpEF patients is associated with reduced exercise capacity, impaired heart rate response, and decreased peripheral oxygen extraction 2
    • Hypertension is a major risk factor for HF development 1

Assessment Algorithm

  1. First Step: Exercise Capacity Assessment

    • Determine metabolic equivalents (METs) the patient can achieve
    • Can be assessed through standardized questionnaires or formal testing
    • Poor exercise capacity (<4 METs) would indicate higher perioperative risk
  2. If Exercise Capacity is Poor:

    • Consider pharmacological stress echocardiogram to further evaluate cardiac function under stress
    • This would provide information about inducible ischemia and ventricular function
  3. If Exercise Capacity is Adequate:

    • No further cardiac testing needed
    • Proceed with optimization of current medications

Why Other Options Are Less Appropriate

  • Option A (No further evaluation): Inappropriate given the elevated RCRI score of 6% and multiple cardiac risk factors
  • Option B (Exercise stress ECG): Less suitable for a patient with HFpEF who may have limited exercise capacity
  • Option C (Pharmacological stress echocardiogram): Would be appropriate only after determining that exercise capacity is inadequate

Management Considerations

  • Medication Management: Continue valsartan for blood pressure control and heart failure management
  • Volume Status: Ensure optimal volume status with appropriate diuretic dosing (furosemide)
  • Glycemic Control: Current HbA1c of 7.2% indicates suboptimal control; consider perioperative glycemic management

Common Pitfalls to Avoid

  1. Overreliance on RCRI score alone without considering functional capacity
  2. Unnecessary cardiac testing in patients with adequate functional capacity
  3. Failing to optimize modifiable risk factors before surgery (blood pressure, volume status, glycemic control)
  4. Not considering the specific impact of HFpEF on perioperative risk

Exercise capacity assessment provides the most clinically relevant information for risk stratification in this patient with multiple cardiac risk factors facing intermediate-risk surgery, making it the best next step in preoperative evaluation.

Related Questions

Does preserved heart failure respond to Farxiga (dapagliflozin)?
How should I manage a patient with heart failure with preserved ejection fraction who presents with congestion, hypertension, diabetes, and atrial fibrillation?
What is the best management approach for an 82-year-old female patient with a history of hypertension (high blood pressure), hyperlipidemia (elevated lipids), coronary artery disease, paroxysmal atrial fibrillation, permanent pacemaker, heart failure with preserved ejection fraction, type 2 diabetes mellitus, chronic kidney disease stage IIIa, hypothyroidism, right hemiplegia after cerebral vascular accident, osteoarthritis, and peripheral neuropathy, presenting with new onset bilateral lower extremity edema and acute volume overload?
What are the appropriate discharge instructions for a 56-year-old male patient with stage IV pancreatic adenocarcinoma, presenting with intractable nausea and vomiting, severe abdominal pain, and new chest pain, who has a history of Heart Failure with Reduced Ejection Fraction (HFrEF), recent atrial fibrillation, Coronary Artery Disease (CAD), Hypertension (HTN), Hyperlipidemia (HLD), poorly controlled Type 2 Diabetes Mellitus (T2DM), Gastroesophageal Reflux Disease (GERD), Obstructive Sleep Apnea (OSA), obesity, and chronic pain on scheduled opioids?
What is the initial treatment approach for a patient with heart failure with preserved ejection fraction (HFpEF) and diabetes?
What is the validity of the coronary artery calcium (CAC) score in assessing cardiovascular risk?
What are the clinical presentations and management options for bronchospasm?
What are the treatment options for Mycoplasma and Ureaplasma infections, bacterial vaginosis, and yeast infections?
What is the efficacy and safety of Leqvio (inclisiran) for lowering Low-Density Lipoprotein Cholesterol (LDL-C)?
Is 1% hydrocortisone (hydrocortisone) cream safe for babies?
What does it mean for a male with prostate cancer to have elevated Luteinizing Hormone (LH) and significantly elevated Prostate-Specific Antigen (PSA) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.